propranolol has been researched along with Alcoholic Cirrhosis in 61 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study tested the hypothesis that reduction in the hyperdynamic systemic circulation with propranolol in patients with alcoholic cirrhosis and distal splenorenal shunt would lead to improved maintenance of portal perfusion." | 9.07 | The effect of propranolol on portal perfusion in patients with alcoholic cirrhosis having distal splenorenal shunt. ( Galloway, JR; Gilmore, GT; Henderson, JM; Mackay, G, 1994) |
| " Seven patients with alcoholic cirrhosis received verapamil, 10 mg i." | 7.67 | Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect. ( Cerini, R; Hadengue, A; Koshy, A; Lebrec, D; Lee, SS; Moreau, R, 1989) |
| "We determined the clearance of antipyrine before, and during, the administration of propranolol in eight male patients with alcoholic cirrhosis and a recent episode of gastrointestinal bleeding." | 7.66 | Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis. ( Bercoff, E; Larrey, D; Lebrec, D; Pessayre, D, 1983) |
| "Tertatolol was rapidly absorbed with a Cmax of 70 +/- 51 micrograms/l at a peak time of 0." | 6.67 | Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension. ( Brouard, R; Caillau, H; Calès, P; Crambes, O; Desmorat, H; Jung, L; Pascal, JP; Rocher, I; Urien, S; Vinel, JP, 1993) |
| "To compare endoscopic sclerotherapy, propranolol and distal splenorenal shunt in the prevention of rebleeding esophageal varices and mortality in alcoholic cirrhotics." | 5.08 | Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study. ( Castro, F; Marquez, E; Medina, R; Molina, A; Oharriz, J; Rubio, CE; Torres, EA; Urbistondo, M, 1996) |
| "This study tested the hypothesis that reduction in the hyperdynamic systemic circulation with propranolol in patients with alcoholic cirrhosis and distal splenorenal shunt would lead to improved maintenance of portal perfusion." | 5.07 | The effect of propranolol on portal perfusion in patients with alcoholic cirrhosis having distal splenorenal shunt. ( Galloway, JR; Gilmore, GT; Henderson, JM; Mackay, G, 1994) |
| " Seven patients with alcoholic cirrhosis received verapamil, 10 mg i." | 3.67 | Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect. ( Cerini, R; Hadengue, A; Koshy, A; Lebrec, D; Lee, SS; Moreau, R, 1989) |
| "1 mg/kg of propranolol on arterial ammonemia was studied in 30 patients with alcoholic cirrhosis comparatively with 10 healthy volunteers." | 3.67 | [Hyperammonemia induced by propranolol in cirrhotic patients. Role of the kidney and influence of the severity of the cirrhosis]. ( Bockel, R; Brandt, CM; Charrault, A; Doffoël, M; Ventre, G; Vetter, D, 1987) |
| "We determined the clearance of antipyrine before, and during, the administration of propranolol in eight male patients with alcoholic cirrhosis and a recent episode of gastrointestinal bleeding." | 3.66 | Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis. ( Bercoff, E; Larrey, D; Lebrec, D; Pessayre, D, 1983) |
| " Additionally, they randomly received either placebo (N = 15) or irbesartan (step-up dosage titration up to 300 mg/d, N = 17)." | 2.73 | Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study. ( Flacke, S; Ghauri, M; Heller, J; Herold, T; Sauerbruch, T; Schepke, M; Stoffel-Wagner, B; Wiest, R, 2008) |
| "Tertatolol was rapidly absorbed with a Cmax of 70 +/- 51 micrograms/l at a peak time of 0." | 2.67 | Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension. ( Brouard, R; Caillau, H; Calès, P; Crambes, O; Desmorat, H; Jung, L; Pascal, JP; Rocher, I; Urien, S; Vinel, JP, 1993) |
| "When molsidomine was added, TAV was further decreased (-17." | 2.67 | [Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound]. ( Blanc, F; Bruel, JM; Ciurana, AJ; Le Quellec, A; Michel, H; Monnin, JL; Pascal, JP; Taourel, P; Vinel, JP, 1992) |
| " Half of the patients (n = 6) were randomized to a treatment group receiving intravenous infusion of propranolol in combination with the meal." | 2.67 | Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis. ( Bendtsen, F; Henriksen, JH; Simonsen, L, 1992) |
| "Propranolol was given twice daily with a mean final dose of 54 +/- 16 mg/day, this resulted in a mean reduction in resting heart rate of 26 +/- 7%." | 2.67 | Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. ( Boyer, J; Burtin, P; Calès, P; Charneau, J; D'Aubigny, N; Joubaud, F; Person, B; Pujol, P; Rossi, V; Valentin, S, 1991) |
| " Daily dosage was determined by the administration of progressively increasing doses of propranolol with the hepatic vein catheter in place to achieve a 25% decrease in hepatic venous pressure gradient, a decrease in hepatic venous pressure gradient to less than 12 mm Hg or a decrease in resting heart rate to less than 55 beats/min." | 2.67 | Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. ( Bosch, J; Conn, HO; Fisher, RL; Garcia-Tsao, G; Grace, ND; Groszmann, RJ; Matloff, DS; Navasa, M; Rodés, J; Wright, SC, 1991) |
| " Patients were chosen randomly to receive oral propranolol (in a dosage to reduce resting pulse rate by 25%) or to undergo long-term injection sclerotherapy." | 2.67 | A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. ( Gimson, AE; Hayes, PC; Hayllar, K; Polson, RJ; Westaby, D; Williams, R, 1990) |
| "Study endpoints were severe recurrence of variceal hemorrhage or death." | 2.67 | Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. ( Birnie, GG; Carter, DC; Garden, OJ; Mills, PR; Murray, GD, 1990) |
| "Atenolol was given at a fixed dose of 100 mg per day." | 2.66 | Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. ( Colombo, M; de Franchis, R; Dioguardi, N; Sangiovanni, A; Tommasini, M, 1989) |
| " The Cmax was significantly higher with C propranolol in both phases." | 2.66 | Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension. ( Blanc, M; Calès, P; Cotonat, J; Grasset, D; Meskens, C; Pascal, JP; Ravaud, A; Vinel, JP, 1989) |
| "Propranolol dosage was titrated according to blood levels." | 2.66 | Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo. ( Huet, PM; Marleau, D; Pomier-Layrargues, G; Villeneuve, JP; Willems, B, 1987) |
| "Propranolol was administered to 5 patients, in doses of 60-80 mg daily." | 1.26 | Injection sclerotherapy of esophageal varices. ( Jorge, AD, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (42.62) | 18.7374 |
| 1990's | 28 (45.90) | 18.2507 |
| 2000's | 5 (8.20) | 29.6817 |
| 2010's | 2 (3.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-Fontenla, F | 1 |
| Castillo-Pradillo, M | 1 |
| Díaz-Gómez, A | 1 |
| Ibañez-Samaniego, L | 1 |
| Gancedo, P | 1 |
| Guzmán-de-Villoria, JA | 1 |
| Fernández-García, P | 1 |
| Bañares-Cañizares, R | 1 |
| García-Martínez, R | 1 |
| Lebrec, L | 1 |
| Chaudhuri, K | 1 |
| Tan, EK | 1 |
| Biswas, A | 1 |
| Henriksen, JH | 7 |
| Bendtsen, F | 7 |
| Hansen, EF | 1 |
| Møller, S | 2 |
| Fuglsang, S | 1 |
| Christensen, E | 1 |
| Laleman, W | 1 |
| Nevens, F | 1 |
| Schepke, M | 1 |
| Wiest, R | 1 |
| Flacke, S | 1 |
| Heller, J | 1 |
| Stoffel-Wagner, B | 1 |
| Herold, T | 1 |
| Ghauri, M | 1 |
| Sauerbruch, T | 1 |
| Colman, JC | 1 |
| Jennings, GL | 1 |
| McLean, AJ | 1 |
| Mignot, PR | 1 |
| Dudley, FJ | 1 |
| Mills, PR | 2 |
| Rae, AP | 1 |
| Farah, DA | 1 |
| Russell, RI | 1 |
| Lorimer, AR | 1 |
| Carter, DC | 2 |
| Larrey, D | 1 |
| Lebrec, D | 7 |
| Bercoff, E | 2 |
| Pessayre, D | 1 |
| Valla, D | 2 |
| Menu, Y | 1 |
| Bataille, C | 1 |
| Gitlin, N | 1 |
| Jorge, AD | 1 |
| Kirkegaard, C | 1 |
| Faber, J | 1 |
| Siersbaek-Nielsen, K | 1 |
| Friis, T | 1 |
| Ahtee, L | 1 |
| Briley, M | 1 |
| Raisman, R | 1 |
| Langer, SZ | 1 |
| Oberti, F | 1 |
| Calès, P | 11 |
| Caillau, H | 1 |
| Crambes, O | 1 |
| Vinel, JP | 5 |
| Desmorat, H | 2 |
| Rocher, I | 1 |
| Jung, L | 1 |
| Urien, S | 1 |
| Brouard, R | 1 |
| Pascal, JP | 8 |
| Bosch, J | 4 |
| Vickers, C | 1 |
| Rhodes, J | 1 |
| Chesner, I | 1 |
| Hillenbrand, P | 1 |
| Dawson, J | 1 |
| Cockel, R | 1 |
| Adams, D | 1 |
| O'Connor, H | 1 |
| Dykes, P | 1 |
| Bradby, H | 1 |
| Kitano, S | 1 |
| Langer, M | 1 |
| Pezzi, A | 1 |
| Gridelli, B | 1 |
| Campanati, L | 1 |
| Prato, P | 1 |
| Di Mauro, P | 1 |
| Quarenghi, E | 1 |
| Peta, M | 1 |
| Pifferi, S | 1 |
| Proietti, D | 1 |
| Gilmore, GT | 1 |
| Henderson, JM | 1 |
| Mackay, G | 1 |
| Galloway, JR | 1 |
| Gerbes, AL | 2 |
| MacMathuna, P | 1 |
| Vlavianos, P | 1 |
| Wendon, J | 1 |
| Gove, CD | 1 |
| Westaby, D | 2 |
| Williams, R | 2 |
| Combis, JM | 1 |
| Badia, P | 1 |
| Barange, K | 1 |
| Payen, JL | 2 |
| Combis, F | 1 |
| Pienkowski, P | 1 |
| Sozzani, P | 1 |
| Kervran, A | 1 |
| Frexinos, J | 1 |
| Urbistondo, M | 1 |
| Torres, EA | 1 |
| Castro, F | 1 |
| Oharriz, J | 1 |
| Medina, R | 1 |
| Molina, A | 1 |
| Marquez, E | 1 |
| Rubio, CE | 1 |
| McCormick, PA | 1 |
| Patch, D | 1 |
| Greenslade, L | 1 |
| Chin, J | 1 |
| McIntyre, N | 1 |
| Burroughs, AK | 1 |
| Perelló, A | 1 |
| Escorsell, A | 1 |
| Bru, C | 1 |
| Gilabert, R | 1 |
| Moitinho, E | 1 |
| García-Pagán, JC | 1 |
| Duhamel, C | 1 |
| Mauillon, J | 1 |
| Berkelmans, I | 1 |
| Bourienne, A | 1 |
| Tranvouez, JL | 1 |
| Christensen, NJ | 1 |
| Ring-Larsen, H | 1 |
| Sørensen, TI | 3 |
| Monnin, JL | 1 |
| Le Quellec, A | 1 |
| Taourel, P | 1 |
| Bruel, JM | 1 |
| Blanc, F | 1 |
| Michel, H | 1 |
| Ciurana, AJ | 1 |
| Simonsen, L | 1 |
| Testa, R | 2 |
| Rodriguez, G | 1 |
| Dagnino, F | 2 |
| Grasso, A | 2 |
| Gris, A | 1 |
| Marenco, S | 1 |
| Nobili, F | 1 |
| Risso, D | 1 |
| Rosadini, G | 1 |
| Celle, G | 2 |
| Poynard, T | 1 |
| Pasta, L | 1 |
| Ideo, G | 1 |
| Pagliaro, L | 1 |
| Ljubicić, N | 1 |
| Ljubicić-Marić, S | 1 |
| Bilić, A | 1 |
| Bunjevac, S | 1 |
| Rossi, V | 1 |
| Burtin, P | 1 |
| Charneau, J | 1 |
| Person, B | 1 |
| Pujol, P | 1 |
| Valentin, S | 1 |
| D'Aubigny, N | 1 |
| Joubaud, F | 1 |
| Boyer, J | 1 |
| Conn, HO | 1 |
| Grace, ND | 1 |
| Groszmann, RJ | 1 |
| Rodés, J | 2 |
| Wright, SC | 1 |
| Matloff, DS | 1 |
| Garcia-Tsao, G | 1 |
| Fisher, RL | 1 |
| Navasa, M | 2 |
| Polson, RJ | 1 |
| Gimson, AE | 1 |
| Hayes, PC | 1 |
| Hayllar, K | 1 |
| Garden, OJ | 1 |
| Birnie, GG | 2 |
| Murray, GD | 1 |
| Colombo, M | 1 |
| de Franchis, R | 1 |
| Tommasini, M | 1 |
| Sangiovanni, A | 1 |
| Dioguardi, N | 1 |
| Grasset, D | 1 |
| Ravaud, A | 1 |
| Meskens, C | 1 |
| Blanc, M | 1 |
| Cotonat, J | 1 |
| Dollet, JM | 1 |
| Champigneulle, B | 1 |
| Evangelista, M | 1 |
| Bigard, MA | 1 |
| Gaucher, P | 1 |
| Hadengue, A | 1 |
| Moreau, R | 1 |
| Cerini, R | 1 |
| Koshy, A | 1 |
| Lee, SS | 2 |
| Caucanas, JP | 1 |
| Suduca, JM | 1 |
| Voigt, JJ | 1 |
| Caujolle, B | 1 |
| Ballet, F | 1 |
| Poupon, R | 1 |
| Snady, H | 1 |
| Feinman, L | 1 |
| McAlpine, LG | 1 |
| Hilditch, TE | 1 |
| Dagg, JH | 1 |
| Pomier-Layrargues, G | 1 |
| Villeneuve, JP | 1 |
| Willems, B | 1 |
| Huet, PM | 1 |
| Marleau, D | 1 |
| Silva, G | 1 |
| Gomis, R | 1 |
| Casamitjana, R | 1 |
| Mastai, R | 1 |
| Rivera, F | 1 |
| Gaudin, C | 1 |
| Geoffroy, P | 1 |
| Braillon, A | 1 |
| Doffoël, M | 1 |
| Brandt, CM | 1 |
| Vetter, D | 1 |
| Ventre, G | 1 |
| Charrault, A | 1 |
| Bockel, R | 1 |
| Becker, U | 1 |
| Bardet-Tassin, P | 1 |
| Lévy, VG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III Study of Intravenous Terlipressin in Patients With Hepatorenal Syndrome Type 1[NCT00089570] | Phase 3 | 112 participants (Actual) | Interventional | 2004-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for propranolol and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Beta-blockers in the prevention of gastrointestinal bleeding.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Esophageal and Gastr | 1990 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esoph | 2006 |
[Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
Topics: Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; | 1995 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemor | 1991 |
[Beta blockaders and portal hypertension].
Topics: Adrenergic beta-Antagonists; Animals; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertensio | 1989 |
27 trials available for propranolol and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Female; Heart Rat | 2004 |
Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphe | 2008 |
Propranolol in decompensated alcoholic cirrhosis.
Topics: Heart; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Propranolol; Risk | 1982 |
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperte | 1984 |
[Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
Topics: Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; | 1995 |
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension.
Topics: Adrenergic beta-Antagonists; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis, Al | 1993 |
Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy.
Topics: Adolescent; Adult; Aged; Blood Pressure; Combined Modality Therapy; Esophageal and Gastric Varices; | 1994 |
Has propranolol rendered sclerotherapy obsolete for poor risk alcoholic cirrhotic patients?
Topics: Combined Modality Therapy; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, | 1994 |
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation?
Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver | 1994 |
The effect of propranolol on portal perfusion in patients with alcoholic cirrhosis having distal splenorenal shunt.
Topics: Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Middle Aged; P | 1994 |
Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Ulcer Agents; Aspirin; Dinoprostone; Enprostil; Femal | 1995 |
Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study.
Topics: Adult; Aged; Antihypertensive Agents; Esophageal and Gastric Varices; Female; Gastrointestinal Hemor | 1996 |
[Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound].
Topics: Adult; Aged; Blood Flow Velocity; Drug Therapy, Combination; Female; Humans; Hypertension, Portal; L | 1992 |
Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. The Study Group of Primary Prophylaxis.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Incidence; Liver Cirrhosis; Liv | 1992 |
Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis.
Topics: Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Blood Pressure; Creatinine; Diet; Hear | 1992 |
Effects of beta-adrenoreceptor antagonists on cerebral blood flow of cirrhotic patients with portal hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Cerebral Cortex; Cerebrovascular | 1991 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemor | 1991 |
Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy.
Topics: Combined Modality Therapy; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemor | 1991 |
Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
Topics: Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorr | 1991 |
A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding.
Topics: Administration, Oral; Blood Pressure; Clinical Trials as Topic; Esophageal and Gastric Varices; Fema | 1990 |
Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial.
Topics: Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Li | 1990 |
Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Atenolol; Clinical Trials a | 1989 |
Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Exercise; Heart Rate; Humans; Hypertension | 1989 |
Sclerotherapy versus propranolol after first variceal haemorrhage in alcoholic cirrhosis.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Pro | 1985 |
Prediction of variceal hemorrhage: a prospective study.
Topics: Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhag | 1988 |
Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestina | 1987 |
Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo.
Topics: Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemo | 1987 |
31 other studies available for propranolol and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
Topics: Adrenergic beta-Antagonists; Alcoholism; Ammonia; Antithyroid Agents; Brain; Carbimazole; Diagnosis, | 2017 |
Successful pregnancy in a woman with liver cirrhosis complicated by recurrent variceal bleeding.
Topics: Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Gestational Age; Humans; | 2012 |
[Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiomyopathies; Electrocardiography; Female; Heart; Hemo | 2004 |
Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis.
Topics: Adult; Antipyrine; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Metabolic | 1983 |
Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Topics: Aged; Cardiac Output; Hepatic Veins; Humans; Liver Circulation; Liver Cirrhosis, Alcoholic; Middle A | 1984 |
Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters.
Topics: Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Propranolo | 1983 |
Injection sclerotherapy of esophageal varices.
Topics: Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; L | 1982 |
A radioimmunoassay of serum 3,5-diiodothyronine.
Topics: Adolescent; Adult; Age Factors; Aged; Diiodothyronines; Female; Humans; Liver Cirrhosis, Alcoholic; | 1981 |
Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients.
Topics: Blood Platelets; Humans; Imipramine; In Vitro Techniques; Kinetics; Liver Cirrhosis, Alcoholic; Prop | 1981 |
Shunt surgery and beta-blockers.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cir | 1994 |
Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade.
Topics: Adult; Aged; Arteries; Atrial Natriuretic Factor; Azygos Vein; Cardiac Output; Female; Hepatic Veins | 1993 |
Metabolic effects of beta-adrenergic receptor blockade in advanced alcoholic cirrhosis.
Topics: Adult; Aged; Blood Pressure; Carbon Dioxide; Female; Heart Rate; Hemodynamics; Humans; Ketone Bodies | 1993 |
Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics; Humans | 1996 |
Clinical vs haemodynamic response to drugs in portal hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studi | 1998 |
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
Topics: Adult; Fatty Liver, Alcoholic; Female; Hepatic Veins; Hepatitis C, Chronic; Humans; Liver Cirrhosis; | 1999 |
Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?
Topics: Adult; Aged; Digitoxin; Female; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis | 2000 |
Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arteries; Atrial Natriuretic Factor; Blood Flow Velocity; | 1992 |
Propranolol and haemodynamic response in cirrhosis.
Topics: Blood Pressure; Catheters, Indwelling; Female; Hemodynamics; Humans; Liver Cirrhosis, Alcoholic; Mal | 1991 |
[Gastro-esophageal symptoms in cirrhosis].
Topics: Aged; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Huma | 1991 |
The effect of propranolol on thyroid function in patients with liver cirrhosis.
Topics: Adult; Aged; Euthyroid Sick Syndromes; Female; Heart Rate; Humans; Liver Cirrhosis, Alcoholic; Male; | 1991 |
[Propranolol and the risk of hepatic encephalopathy in liver cirrhosis].
Topics: Ammonia; Cerebrovascular Circulation; Electroencephalography; Esophageal and Gastric Varices; Heart | 1989 |
Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Topics: Drug Synergism; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension, Portal; Ketanserin; L | 1989 |
Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.
Topics: Female; Galactose; Humans; Indocyanine Green; Liver; Liver Cirrhosis, Alcoholic; Male; Middle Aged; | 1988 |
Relationship among beta-adrenergic blockade, propranolol concentration, and liver function in patients with cirrhosis.
Topics: Female; Heart Rate; Humans; Isoproterenol; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Functi | 1988 |
Bleeding colonic varices controlled by propranolol.
Topics: Colonic Diseases; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhos | 1988 |
Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Drug Resistance; Female; Glucagon; Humans; Liver Cirrhosi | 1988 |
Propranolol reduces the response of serum bile acids to oral chenodeoxycholic acid, possibly as a reflex reaction to reduced portal blood flow in healthy and cirrhotic subjects.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Female; Humans; Intestinal Absorption; Liver Circulatio | 1988 |
Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol.
Topics: Adult; Azygos Vein; Drug Interactions; Epinephrine; Esophageal and Gastric Varices; Female; Gastroin | 1987 |
[Hyperammonemia induced by propranolol in cirrhotic patients. Role of the kidney and influence of the severity of the cirrhosis].
Topics: Ammonia; Female; Humans; Injections, Intravenous; Kidney; Liver Cirrhosis, Alcoholic; Male; Middle A | 1987 |
Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Intesti | 1987 |
[Propranolol and hemorrhage in cirrhosis].
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirr | 1985 |